PMDA — authorised 5 November 2004
- Marketing authorisation holder: Tanabe Seiyaku Co., Ltd.
- Status: approved
🇯🇵 Valcyte in Japan
PMDA authorised Valcyte on 5 November 2004
Marketing authorisation
Valcyte in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Japan
Frequently asked questions
Is Valcyte approved in Japan?
Yes. PMDA authorised it on 5 November 2004.
Who is the marketing authorisation holder for Valcyte in Japan?
Tanabe Seiyaku Co., Ltd. holds the Japanese marketing authorisation.